Modeling: Customized, realistic projections to fuel client growth

While we’d love to boast about our modeling work, we respect the need for full confidentiality given the potential impact on our clients’ financials and investor relations.

Here are examples of the wide range of objectives and roles our modeling has delivered on:

• Prioritize Clinical Planning and Indications for Business Development Acquisition and Partnership Strategy
  • Sized and prioritized wide range of indications and segments for potential expansion in support of a global biopharmaceutical company with leadership positions in a consumer-driven $50+ billion category.
  • Projected a new technology sales opportunity across the different potential segments enabling a commercial and clinical strategy for acquisitions in a large and growing market for the same global company.

• Enable New Product Acquisition Decisions
  • Evaluated the hcp and consumer proposition and opportunity potential to guide a small, single product biotech considering an asset acquisition into a new category and distribution channel. Planned and integrated hcp and consumer research to customize our model to project patient acquisition and sales by type of doctor consumer relies on to treat this specific condition. We also customized our hcp model to project sales to triangulate with consumer projections for added rigor.

• Drive Commercial Investment Decisions
  • Determined a new unbiased baseline of brand sales for a global biopharmaceutical company that had recently acquired a new product in a new segment that was not meeting expectations. Assessed the ROI of alternative commercial investment strategies to optimize sales growth moving forward.
  • Assessed the ROI of multiple commercialization launch strategies to ignite consumer action for a new product launching into a well-established category. Provided sales growth and ROI estimates for branded and unbranded plans, national TV and targeted digital strategies.

• Provide Concrete Market and Brand Analytics to Support Corporations’ Investor Relations and Capital Financing
  • Deliver a full assessment and projection of a small biotech’s transformational product portfolio among US consumers to support their value proposition for a Series B Capital Raise. This included the integration of a large quantitative consumer sizing and conjoint study to project US market and brand opportunity and to better understand the sales impact of different potential price points.